Skip to main content
Equibles

Peter N. Kellogg

Alnylam Pharmaceuticals, Inc. (ALNY)

Board Member

Alnylam Pharmaceuticals, Inc. (ALNY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Peter N. Kellogg

Peter N. Kellogg is recorded as Board Member at Alnylam Pharmaceuticals, Inc. (ALNY). Alnylam Pharmaceuticals, Inc. reported in an 8-K filed September 28, 2023 that Peter N. Kellogg was appointed Chair of the Audit Committee of the Board, effective September 29, 2023. Alnylam Pharmaceuticals, Inc. reported in an 8-K filed March 8, 2023 that Peter N. Kellogg was appointed Class II director, effective March 7, 2023.

“Upon the effectiveness of Ms. Fanucci's resignation, Peter N. Kellogg will become the Chair of the Audit Committee of the Board.”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed September 28, 2023 · Read the filing
“Effective as of March 7, 2023, the Board of Directors (the "Board") of Alnylam Pharmaceuticals, Inc. (the "Company"), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company's Board from twelve to thirteen and elected Peter N. Kellogg to fill the newly created vacancy.”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed March 8, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Alnylam Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.